Fig. 4From: Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countriesExpected Value of Partially Perfect Information, example of a Senegal, b Vietnam, and c AngolaBack to article page